Published in Proc Natl Acad Sci U S A on August 04, 1998
MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer. Cancer Metastasis Rev (2008) 1.34
Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin Drug Deliv (2010) 1.30
The glycosylphosphatidylinositol (GPI) biosynthetic pathway of bloodstream-form Trypanosoma brucei is dependent on the de novo synthesis of inositol. Mol Microbiol (2006) 1.14
Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness. EMBO J (2004) 1.09
Inositol deacylation by Bst1p is required for the quality control of glycosylphosphatidylinositol-anchored proteins. Mol Biol Cell (2005) 1.08
PIG-W is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor. Mol Biol Cell (2003) 0.99
Specificity of GlcNAc-PI de-N-acetylase of GPI biosynthesis and synthesis of parasite-specific suicide substrate inhibitors. EMBO J (2001) 0.98
Biosynthesis and deficiencies of glycosylphosphatidylinositol. Proc Jpn Acad Ser B Phys Biol Sci (2014) 0.95
Purification, cloning and characterization of a GPI inositol deacylase from Trypanosoma brucei. EMBO J (2001) 0.90
GPI-anchored proteins do not reside in ordered domains in the live cell plasma membrane. Nat Commun (2015) 0.85
Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling. J Lipid Res (2015) 0.83
Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier. Ther Deliv (2015) 0.81
Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus. Mol Microbiol (2014) 0.79
Analysis of membrane topology and identification of essential residues for the yeast endoplasmic reticulum inositol acyltransferase Gwt1p. J Biol Chem (2011) 0.79
Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses. J Biol Chem (2016) 0.75
Heritable disorders in the metabolism of the dolichols: A bridge from sterol biosynthesis to molecular glycosylation. Am J Med Genet C Semin Med Genet (2012) 0.75
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood (1975) 15.95
Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu Rev Biochem (1988) 7.57
CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med (1989) 4.19
Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein. J Exp Med (1986) 3.68
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med (1985) 3.33
Decay-accelerating factor: biochemistry, molecular biology, and function. Annu Rev Immunol (1989) 3.20
Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry (1986) 2.97
Molecular cloning and sequence analysis of human placental alkaline phosphatase. J Biol Chem (1986) 2.88
A novel pathway for glycan assembly: biosynthesis of the glycosyl-phosphatidylinositol anchor of the trypanosome variant surface glycoprotein. Cell (1989) 2.56
Glycosyl-phosphatidylinositol: a versatile anchor for cell surface proteins. FASEB J (1989) 2.31
Lipid analysis of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase. Palmitoylation of inositol results in resistance to phosphatidylinositol-specific phospholipase C. J Biol Chem (1988) 2.18
Structural characterization of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase by fast atom bombardment mass spectrometry. J Biol Chem (1988) 1.79
Non-lytic release of acetylcholinesterase from erythrocytes by a phosphatidylinositol-specific phospholipase C. FEBS Lett (1977) 1.67
Yeast Gaa1p is required for attachment of a completed GPI anchor onto proteins. J Cell Biol (1995) 1.64
Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage. J Immunol (1990) 1.54
Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine. J Biol Chem (1992) 1.49
An active carbonyl formed during glycosylphosphatidylinositol addition to a protein is evidence of catalysis by a transamidase. J Biol Chem (1995) 1.38
Biosynthesis of phosphatidylinositol glycan-anchored membrane proteins. Design of a simple protein substrate to characterize the enzyme that cleaves the COOH-terminal signal peptide. J Biol Chem (1991) 1.31
Candidate glycophospholipid precursor for the glycosylphosphatidylinositol membrane anchor of Trypanosoma brucei variant surface glycoproteins. J Biol Chem (1988) 1.29
Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor. J Exp Med (1987) 1.27
Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. Eur J Biochem (1983) 1.26
Chemical characterization of the membrane-anchoring domain of human placental alkaline phosphatase. J Biol Chem (1988) 1.22
Transfer of glycosyl-phosphatidylinositol membrane anchors to polypeptide acceptors in a cell-free system. J Cell Biol (1991) 1.15
Characterization of glycophospholipid intermediate in the biosynthesis of glycophosphatidylinositol anchors accumulating in the Thy-1-negative lymphoma line SIA-b. J Biol Chem (1991) 1.15
Glycolipid reanchoring of T-lymphocyte surface antigen CD8 using the 3' end sequence of decay-accelerating factor's mRNA. Proc Natl Acad Sci U S A (1988) 1.13
Glycoinositol phospholipid anchor-defective K562 mutants with biochemical lesions distinct from those in Thy-1- murine lymphoma mutants. J Biol Chem (1994) 1.12
The affected gene underlying the class K glycosylphosphatidylinositol (GPI) surface protein defect codes for the GPI transamidase. Proc Natl Acad Sci U S A (1997) 1.12
Biosynthesis of placental alkaline phosphatase and its post-translational modification by glycophospholipid for membrane-anchoring. J Biol Chem (1988) 1.07
Identification of six complementation classes involved in the biosynthesis of glycosylphosphatidylinositol anchors in Saccharomyces cerevisiae. J Cell Biol (1995) 1.06
Complexity of ethanolamine phosphate addition in the biosynthesis of glycosylphosphatidylinositol anchors in mammalian cells. J Biol Chem (1992) 1.04
Anchoring and degradation of glycolipid-anchored membrane proteins by L929 versus by LM-TK- mouse fibroblasts: implications for anchor biosynthesis. Mol Cell Biol (1991) 1.02
Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59. Clin Exp Immunol (1992) 0.99
The solubilization of tetrameric alkaline phosphatase from human liver and its conversion into various forms by phosphatidylinositol phospholipase C or proteolysis. J Biol Chem (1988) 0.97
Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A (1992) 0.96
Derivation and characterization of glycoinositol-phospholipid anchor-defective human K562 cell clones. J Biol Chem (1992) 0.96
A defect in glycosylphosphatidylinositol (GPI) transamidase activity in mutant K cells is responsible for their inability to display GPI surface proteins. Proc Natl Acad Sci U S A (1996) 0.96
Biosynthesis of phosphatidylinositol-glycan (PI-G)-anchored membrane proteins in cell-free systems: PI-G is an obligatory cosubstrate for COOH-terminal processing of nascent proteins. Proc Natl Acad Sci U S A (1992) 0.96
Conversion of human erythrocyte acetylcholinesterase from an amphiphilic to a hydrophilic form by phosphatidylinositol-specific phospholipase C and serum phospholipase D. Eur J Biochem (1989) 0.92
Atypical mannolipids characterize Thy-1-negative lymphoma mutants. Mol Cell Biol (1991) 0.92
A candidate mammalian glycoinositol phospholipid precursor containing three phosphoethanolamines. J Biol Chem (1993) 0.90
Hemoglobin expression in clones of K562 cell line. Eur J Biochem (1982) 0.89
Quantitative identification of N-terminal amino acids in proteins by radiolabeled reductive methylation and amino acid analysis: application to human erythrocyte acetylcholinesterase. Anal Biochem (1985) 0.89
Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction. Exp Cell Res (1983) 0.86
Molecular forms of acetylcholinesterase in two sublines of human erythroleukemia K562 cells. Sensitivity or resistance to phosphatidylinositol-specific phospholipase C and biosynthesis. Eur J Biochem (1990) 0.85
Purification and parital characterization of two genetic variants of placental alkaline phosphatase. Biochem Genet (1976) 0.82
Addition of lipid substituents of mammalian protein glycosylphosphoinositol anchors. Mol Cell Biol (1994) 0.81
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science (1972) 11.71
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys (1973) 7.81
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Controlled trial of three different antismoking interventions in general practice. Br Med J (Clin Res Ed) (1984) 6.25
Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem (1986) 6.03
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med (1984) 5.47
Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem (1988) 5.18
The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry (1990) 4.10
Hydroxylation-induced migration: the NIH shift. Recent experiments reveal an unexpected and general result of enzymatic hydroxylation of aromatic compounds. Science (1967) 3.60
Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int (2008) 3.54
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med (1982) 3.42
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med (1985) 3.33
Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03
Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry (1986) 2.97
Automatic Monitoring of primary amines in preparative column effluents with fluorescamine. Anal Biochem (1975) 2.88
Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med (1987) 2.86
Membrane complement receptors specific for bound fragments of C3. Adv Immunol (1985) 2.80
Formation of hydroxyproline in collagen. Science (1966) 2.68
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci U S A (1987) 2.62
Prolyl hydroxylase. Adv Enzymol Relat Areas Mol Biol (1974) 2.61
Molecular cloning establishes proenkephalin as precursor of enkephalin-containing peptides. Nature (1982) 2.53
1,2-naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene. Biochemistry (1970) 2.47
Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys (1973) 2.23
Photometric assay of dopamine- -hydroxylase activity in human blood. Clin Chem (1972) 2.14
The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. J Clin Psychiatry (2001) 1.97
Randomised controlled trial of effectiveness of Leicester hospital at home scheme compared with hospital care. BMJ (1999) 1.97
A method for immediate visualization of proteins in acrylamide gels and its use for preparation of antibodies to enzymes. Anal Biochem (1969) 1.92
Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci U S A (1985) 1.87
Isolation and characterization of the opioid peptides from rat pituitary: beta-lipotropin. Proc Natl Acad Sci U S A (1977) 1.86
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1986) 1.85
p-Chlorophenylalanine-induced chemical manifestations of phenylketonuria in rats. Science (1967) 1.82
An about 50,000-dalton protein in adrenal medulla: a common precursor of [Met]- and [Leu]enkephalin. Science (1980) 1.81
A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells. Biochem Biophys Res Commun (1993) 1.80
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology (2001) 1.79
Functional expression of furin demonstrating its intracellular localization and endoprotease activity for processing of proalbumin and complement pro-C3. J Biol Chem (1991) 1.76
Serotonin, Norepinephrine, and Related Compounds in Bananas. Science (1958) 1.75
Competition for immune complexes by red cells in human blood. J Clin Lab Immunol (1982) 1.74
Cloning and sequencing of human intestinal alkaline phosphatase cDNA. Proc Natl Acad Sci U S A (1987) 1.74
Development of guidelines to facilitate improved support of South Asian carers by primary health care teams. Qual Health Care (2001) 1.72
Primary structure of rat liver dipeptidyl peptidase IV deduced from its cDNA and identification of the NH2-terminal signal sequence as the membrane-anchoring domain. J Biol Chem (1989) 1.71
Collagen chain formation and peptidyl proline hydroxylation in monolayer tissue cultures of L-929 fibroblasts. Arch Biochem Biophys (1969) 1.71
Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts. Transplantation (2000) 1.66
Aspartic acid-484 of nascent placental alkaline phosphatase condenses with a phosphatidylinositol glycan to become the carboxyl terminus of the mature enzyme. Proc Natl Acad Sci U S A (1988) 1.64
Expression cloning of a Na(+)-independent neutral amino acid transporter from rat kidney. Proc Natl Acad Sci U S A (1992) 1.64
Phosphatidylinositol glycan (PI-G) anchored membrane proteins. Amino acid requirements adjacent to the site of cleavage and PI-G attachment in the COOH-terminal signal peptide. J Biol Chem (1992) 1.64
The Parental Bonding Instrument. A decade of research. Soc Psychiatry Psychiatr Epidemiol (1990) 1.63
Placental alkaline phosphatase as a tumor marker for seminoma. Cancer Res (1982) 1.63
Putative enkephalin precursors in bovine adrenal medulla. Biochem Biophys Res Commun (1979) 1.63
The GM130 and GRASP65 Golgi proteins cycle through and define a subdomain of the intermediate compartment. Nat Cell Biol (2001) 1.63
Selectivity of the cleavage/attachment site of phosphatidylinositol-glycan-anchored membrane proteins determined by site-specific mutagenesis at Asp-484 of placental alkaline phosphatase. Proc Natl Acad Sci U S A (1990) 1.62
Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial. BMJ (1999) 1.62
Generation of asymmetry during development. Segregation of type-specific proteins in Caulobacter. J Cell Biol (1979) 1.62
Experiments on hydraulic jumps in turbidity currents near a canyon-fan transition. Science (1989) 1.61
Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol (1965) 1.60
Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J Pharmacol Exp Ther (1966) 1.58
The role of arene oxide-oxepin systems in the metabolism of aromatic substrates. 3. Formation of 1,2-naphthalene oxide from naphthalene by liver microsomes. J Am Chem Soc (1968) 1.58
The life skills profile: a measure assessing function and disability in schizophrenia. Schizophr Bull (1989) 1.57
Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry (1996) 1.56
Preparation and properties of a homogeneous aromatic L-amino acid decarboxylase from hog kidney. Arch Biochem Biophys (1970) 1.55
Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage. J Immunol (1990) 1.54
A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo. Biochem Pharmacol (1967) 1.54
Brefeldin A arrests the intracellular transport of a precursor of complement C3 before its conversion site in rat hepatocytes. FEBS Lett (1987) 1.53
Parental characteristics in relation to depressive disorders. Br J Psychiatry (1979) 1.53
COOH-terminal requirements for the correct processing of a phosphatidylinositol-glycan anchored membrane protein. J Biol Chem (1988) 1.52
Reliability of long-term recall of participation in physical activity by middle-aged men and women. Am J Epidemiol (1991) 1.51
What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry (2001) 1.51
Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol (2000) 1.50
Time-dependent loss of surface complement regulatory activity during storage of donor blood. Transfusion (1993) 1.49
Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine. J Biol Chem (1992) 1.49
Continuity and change in medical care for young adults with disabilities. J R Coll Physicians Lond (1987) 1.48
Isolation and characterization of the opioid peptides from rat pituitary: beta-endorphin. Proc Natl Acad Sci U S A (1977) 1.47
Isolation of the opioid heptapeptide Met-enkephalin [Arg6,Phe7] from bovine adrenal medullary granules and striatum. Proc Natl Acad Sci U S A (1979) 1.47
Purification and properties of collagen proline hydroxylase from newborn rat skin. Arch Biochem Biophys (1970) 1.46
Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin. Epidemiol Infect (2003) 1.45
Beliefs about outcomes for mental disorders: a comparative study of primary health practitioners and psychiatrists in Singapore. Singapore Med J (2000) 1.45
Expression of active, membrane-bound human placental alkaline phosphatase by transfected simian cells. Proc Natl Acad Sci U S A (1987) 1.44
Effect of physiotherapy on sickness absence in industry: a comparative study. J Soc Occup Med (1991) 1.43
Biosynthesis of glycosylphosphatidylinositol (GPI)-anchored membrane proteins in intact cells: specific amino acid requirements adjacent to the site of cleavage and GPI attachment. J Cell Biol (1993) 1.43
Respiratory symptoms and wheat flour exposure: a study of flour millers. Occup Med (Lond) (2000) 1.42
Personality as a vulnerability factor to depression. Br J Psychiatry (1991) 1.41
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. J Clin Invest (1988) 1.41
p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene (1998) 1.41
Dural arteriovenous fistula in association with heterotopic brain nodule in the transverse sinus. AJNR Am J Neuroradiol (1998) 1.40
Development of a scale to measure interpersonal sensitivity. Aust N Z J Psychiatry (1989) 1.40
Neural network subtyping of depression. Aust N Z J Psychiatry (1998) 1.39
Structural characterization of argingipain, a novel arginine-specific cysteine proteinase as a major periodontal pathogenic factor from Porphyromonas gingivalis. Arch Biochem Biophys (1995) 1.39
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol (2012) 1.38
An active carbonyl formed during glycosylphosphatidylinositol addition to a protein is evidence of catalysis by a transamidase. J Biol Chem (1995) 1.38
'New' and 'old' antidepressants: all equal in the eyes of the lore? Br J Psychiatry (2001) 1.38
Increased turnover of arterial collagen in hypertensive rats. Proc Natl Acad Sci U S A (1978) 1.36
Characterization of DNA used to assay sera for anti-DNA antibodies; determination of the specificities of anti-DNA antibodies in SLE and non-SLE rheumatic disease states. J Immunol (1977) 1.36
The use of dopamine -hydroxylase as a marker for the central noradrenergic nervous system in rat brain. Proc Natl Acad Sci U S A (1972) 1.35
Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. J Antimicrob Chemother (1983) 1.34